NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $478,000 | – | 22,128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $82,950,000 | 2.19% |
MAVERICK CAPITAL LTD | 5,678,221 | $94,202,000 | 1.75% |
Rhenman & Partners Asset Management AB | 1,000,000 | $16,590,000 | 1.48% |
Goodman Financial Corp | 119,198 | $1,977,000 | 0.92% |
Bellevue Group AG | 3,632,358 | $60,261,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 477,004 | $7,914,000 | 0.53% |
Parametrica Management Ltd | 13,658 | $226,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 592,930 | $9,837,000 | 0.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,110,000 | 0.36% |
Burleson & Company, LLC | 92,836 | $1,617,000 | 0.31% |